SCHEMBL14975863

SCHEMBL14975863

CCNc1cc[nH]c(=O)c1C(=O)N(c1ccc(F)cc1)c1cc(F)c(Oc2ccnc(NC(C)=O)c2)cc1F

nearest known ligand 0.42

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 10/20 0.42
▸ KDR P35968 9/20 0.42
▸ AXL P30530 2/20 0.38
▸ NTRK1 P04629 1/20 0.38
▸ TEK Q02763 1/20 0.38
▸ NTRK3 Q16288 1/20 0.38
▸ NTRK2 Q16620 1/20 0.38
▸ MAPK14 Q16539 5/20 0.37
▸ GCK P35557 1/20 0.37
▸ BRAF P15056 1/20 0.35
▸ MAPK13 O15264 2/20 0.34
▸ PIK3C3 Q8NEB9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14975764 0.93 MET (0.43) METKDRAXLNTRK1TEK
SCHEMBL14976137 0.92 KDR (0.48) METKDRAXLNTRK1TEK
SCHEMBL14975552 0.90 MET (0.44) METKDRAXLNTRK1TEK
SCHEMBL14975604 0.87 AXL (0.46) METKDRAXLNTRK1TEK
SCHEMBL14975396 0.84 MET (0.41) METKDRAXLNTRK1NTRK2
SCHEMBL14975545 0.84 MET (0.47) METKDRAXLNTRK1TEK
SCHEMBL14975035 0.83 MET (0.42) METKDRAXLNTRK1TEK
SCHEMBL14975389 0.83 MET (0.46) METKDRAXLNTRK1TEK
SCHEMBL14975335 0.82 AXL (0.47) METKDRAXLNTRK1TEK
SCHEMBL14975314 0.82 KDR (0.48) METKDRAXLNTRK1TEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2782577-A2 PYRIDONE AMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES Deciphera Pharmaceuticals, LLC. (US) 2014-10-01 — — EP disclosed
WO-2013078295-A2 PYRIDONE AMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES DECIPHERA PHARMACEUTICALS, LLC (US) 2013-05-30 — — WO disclosed
Send feedback